The Amoxicillin and Clavulanate Pota, cataloged under National Stock Number 6505-01-431-0403, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sandoz Inc.. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-431-0403 |
| Primary Part Number | NDC00781-1831-20 |
| Item Name | Amoxicillin and Clavulanate Pota |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sandoz Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 20.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00781-1831-20 PRIMARY | Sandoz Inc. (USA) |
| NDC00093-2274-34 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 96-0302 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-431-0403 is a Amoxicillin and Clavulanate Pota, manufactured by Sandoz Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-431-0403 has 2 manufacturer part numbers on file: NDC00781-1831-20 (Sandoz Inc.), NDC00093-2274-34 (Teva Pharmaceuticals Usa, Inc.).
Key specifications for NDC00781-1831-20: Primary Container Content Quantity: 20.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: 500 MG AMOXICILLIN EQUIVALENT AND 125 MG OF CLAVULANIC ACID EQUIVALENT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.